COVID-19 (death) |
Treatment |
Concomitant medication [Treated with anti-tumor necrosis factor vs. Not received] |
Odds ratio: 0.400 (0.040-3.780)
|
Bezzio
|
|
|
COVID-19 (death) |
Treatment |
Concomitant medication [Treated with corticosteroid vs. Not received] |
Odds ratio: 6.280 (0.890-44.240)
|
Bezzio
|
|
|
COVID-19 (death) |
Comorbidities |
Ulcerative colitis [Present vs. Not present] |
Odds ratio: 2.950 (0.310-27.730)
|
Bezzio
|
|
|
COVID-19 (death) |
Comorbidities |
Inflammatory bowel disease [Present vs. Not present] |
Odds ratio: 8.450 (1.260-56.560)
|
Bezzio
|
|
|
COVID-19 (death) |
Comorbidities |
Charlson Comorbidity Index (CCI) [CCI score >1 vs. Not applicable] |
Odds ratio: 16.660 (1.800-153.900)
|
Bezzio
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [>65 years vs. <=65 years] |
Odds ratio: 19.600 (2.950-130.600)
|
Bezzio
|
|
|
COVID-19 (Pneumonia) |
Treatment |
Concomitant medication [Treated with Vedolizumab vs. Not received] |
Odds ratio: 0.530 (0.160-1.730)
|
Bezzio
|
|
|
COVID-19 (Pneumonia) |
Treatment |
Concomitant medication [Treated with anti-tumor necrosis factor vs. Not received] |
Odds ratio: 1.180 (0.470-2.970)
|
Bezzio
|
|
|
COVID-19 (Pneumonia) |
Treatment |
Concomitant medication [Treated with Thiopurines vs. Not received] |
Odds ratio: 1.210 (0.220-6.400)
|
Bezzio
|
|
|
COVID-19 (Pneumonia) |
Treatment |
Concomitant medication [Treated with corticosteroid vs. Not received] |
Odds ratio: 4.940 (0.950-25.550)
|
Bezzio
|
|
|
COVID-19 (Pneumonia) |
Comorbidities |
Inflammatory bowel disease [Present vs. Not present] |
Odds ratio: 10.250 (2.110-49.730)
|
Bezzio
|
|
|
COVID-19 (Pneumonia) |
Comorbidities |
Ulcerative colitis [Present vs. Not present] |
Odds ratio: 2.720 (1.060-6.990)
|
Bezzio
|
|
|
COVID-19 (Pneumonia) |
Comorbidities |
Charlson Comorbidity Index (CCI) [CCI score >1 vs. Not applicable] |
Odds ratio: 2.910 (1.060-9.210)
|
Bezzio
|
|
|
COVID-19 (Pneumonia) |
Patient characteristics |
Age [>65 years vs. <=65 years] |
Odds ratio: 5.870 (1.150-29.660)
|
Bezzio
|
|
|
COVID-19 (death) |
Findings |
Radiological finding during hospitalization [Pleural effusion vs. Normal] |
Odds ratio: 1.357 (0.303-6.083)
|
Zhang
|
|
|
COVID-19 (death) |
Findings |
Radiological finding during hospitalization [Calcification vs. Negative] |
Odds ratio: 1.714 (0.375-7.836)
|
Zhang
|
|
|
COVID-19 (death) |
Findings |
Radiological finding during hospitalization [Emphysema present vs. Normal] |
Odds ratio: 21.000 (1.909-230.962)
|
Zhang
|
|
|
COVID-19 (death) |
Findings |
Radiological finding during hospitalization [GGO with clear margin vs. Normal] |
Odds ratio: 1.000 (0.183-5.460)
|
Zhang
|
|
|
COVID-19 (death) |
Findings |
Radiological finding during hospitalization [Consolidation on chest CT vs. Normal] |
Odds ratio: 0.643 (0.158-2.613)
|
Zhang
|
|
|
COVID-19 (death) |
Symptoms |
Diarrhoea [Present vs. Not present] |
Odds ratio: 0.683 (0.074-6.253)
|
Zhang
|
|
|
COVID-19 (death) |
Symptoms |
Nausea/vomiting [Present vs. Not present] |
Odds ratio: 1.278 (0.127-12.806)
|
Zhang
|
|
|
COVID-19 (death) |
Symptoms |
Loss of appetite [Present vs. Not present] |
Odds ratio: 0.722 (0.181-2.875)
|
Zhang
|
|
|
COVID-19 (death) |
Symptoms |
Fatigue [Present vs. Not present] |
Odds ratio: 0.483 (0.121-1.927)
|
Zhang
|
|
|
COVID-19 (death) |
Symptoms |
Dyspnea [Present vs. Not present] |
Odds ratio: 0.783 (0.196-3.117)
|
Zhang
|
|
|
COVID-19 (death) |
Symptoms |
Sputum production [Present vs. Not present] |
Odds ratio: 0.786 (0.202-3.060)
|
Zhang
|
|
|
COVID-19 (death) |
Symptoms |
Cough [Present vs. Not present] |
Odds ratio: 1.263 (0.235-6.777)
|
Zhang
|
|
|
COVID-19 (death) |
Symptoms |
Fever [Present vs. Not present] |
Odds ratio: 1.976 (0.221-17.623)
|
Zhang
|
|
|
COVID-19 (death) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 6.000 (1.253-28.742)
|
Zhang
|
|
|
COVID-19 (death) |
Comorbidities |
Stroke [Present vs. Not present] |
Odds ratio: 2.875 (0.449-18.395)
|
Zhang
|
|
|
COVID-19 (death) |
Comorbidities |
Peptic ulcer [Present vs. Not present] |
Odds ratio: 0.583 (0.065-5.265)
|
Zhang
|
|
|
COVID-19 (death) |
Comorbidities |
COPD [Present vs. Not present] |
Odds ratio: 2.875 (0.449-18.395)
|
Zhang
|
|
|
COVID-19 (death) |
Comorbidities |
Coronary heart disease [Present vs. Not present] |
Odds ratio: 1.519 (0.336-6.871)
|
Zhang
|
|
|
COVID-19 (death) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 1.185 (0.295-4.762)
|
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
D-dimer [1 unit increase vs. Not applicable] |
Odds ratio: 1.120 (1.030-1.210)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
PT [Abnormal vs. Normal] |
Odds ratio: 1.250 (1.070-1.480)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
APTT [Abnormal vs. Normal] |
Odds ratio: 1.120 (1.050-1.180)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Platelet count [1 unit increase vs. Not applicable] |
Odds ratio: 1.000 (0.990-1.000)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
HS-cTnI [1 unit increase vs. Not applicable] |
Odds ratio: 1.010 (1.000-1.020)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Myoglobin (MYO) [1 unit increase vs. Not applicable] |
Odds ratio: 1.010 (1.000-1.030)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable] |
Odds ratio: 1.650 (1.030-2.780)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Albumin/globulin ratio [1 unit increase vs. Not applicable] |
Odds ratio: 0.120 (0.020-0.770)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Albumin [1 unit increase vs. Not applicable] |
Odds ratio: 0.920 (0.870-0.980)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
LDH [1 unit increase vs. Not applicable] |
Odds ratio: 1.000 (1.000-1.000)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Monocytes [1% increase vs. Not applicable] |
Odds ratio: 0.880 (0.790-0.980)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Neutrophils [1% increase vs. Not applicable] |
Odds ratio: 1.060 (1.030-1.090)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Leucocyte count [1 unit increase vs. Not applicable] |
Odds ratio: 1.110 (1.010-1.220)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CD3-CD16+CD56+ natural killer cells [1% increase vs. Not applicable] |
Odds ratio: 0.850 (0.720-0.990)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CD4+ T cells [1% increase vs. Not applicable] |
Odds ratio: 0.840 (0.710-0.980)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CD3-CD19+ B-cell count [1 unit increase vs. Not applicable] |
Odds ratio: 0.980 (0.960-1.000)
§ |
Tian
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphocyte count [1 unit increase vs. Not applicable] |
Odds ratio: 0.560 (0.310-1.000)
§ |
Tian
|
|
|